675 filings
S-8
ABEO
Abeona Therapeutics Inc
15 May 24
Registration of securities for employees
4:31pm
10-Q
2024 Q1
ABEO
Abeona Therapeutics Inc
Quarterly report
15 May 24
7:35am
8-K
ABEO
Abeona Therapeutics Inc
15 May 24
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
7:30am
8-K
ABEO
Abeona Therapeutics Inc
3 May 24
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
5:16pm
424B5
ABEO
Abeona Therapeutics Inc
3 May 24
Prospectus supplement for primary offering
5:11pm
8-K
0qydt0a7j
3 May 24
Results of Operations and Financial Condition
6:45am
8-K
gm7dupznn3 lmqvhy0qj
24 Apr 24
Departure of Directors or Certain Officers
4:05pm
8-K
0ifdhua7ueda 5xe73
22 Apr 24
Abeona Therapeutics Provides Regulatory Update on Pz-cel
4:05pm
8-K
8x2bbjfxwrl4x 585p
18 Mar 24
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
8:36am
8-K
r10ex9dovea v4g31
8 Jan 24
Abeona Therapeutics Announces $50 Million Credit Facility
7:35am
8-K
6tjmlzpmfkcy3q8
27 Nov 23
Other Events
7:30am
8-K
p1q4cy
13 Nov 23
Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments
7:35am
8-K
le2u8
18 Oct 23
Changes in Registrant's Certifying Accountant
7:30am
S-8
mkufux9 mvyjdr0tu9
10 Oct 23
Registration of securities for employees
4:30pm
8-K
8vmkih7cny3
8 Aug 23
Abeona Therapeutics Reports Second Quarter 2023 Financial Results
8:30am
8-K
2pb9xbvyonbtu
7 Jul 23
Abeona Therapeutics Announces Closing of $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
8:41am